Form 4 for GH Guardant Health, Inc.
Accepted 2026-04-22 18:17:36 ET · period of report 2026-04-21 · accession 0001258394-26-000008 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-04-22 18:17 | 2026-04-21 | GH | MIGNONE ROBERTO | Dir | M - OptEx | $0.00 | +264 | 4,751 | +6% | $0 |
| D | 2026-04-22 18:17 | 2026-04-21 | GH | MIGNONE ROBERTO | Dir | M - OptEx | $0.00 | -264 | 7,920 | -3% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-04-21 | M | A | 264 | $0.00 | 4,751 | D | — | — | |
| 2 | Derivative | Restricted Stock Units | 2026-04-21 | M | D | 264 | $0.00 | 7,920 | D | $0.00 · — to — | 264 Common Stock | (F1) The restricted stock unit award granted on November 8, 2024 vests over a four-year period. 25% of the shares subject to such award vested on October 21, 2025 and the remaining 75% vests monthly for the three-year period thereafter. (F2) Not applicable for Restricted Stock Units. |